Interferon beta-1a biosimilar (Biocad)

干扰素β-1a生物类似药 (Biocad)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon beta-1a biosimilar (Biocad)
Drug Alias Name干扰素beta-1a生物仿制药(Biocad)BCD-033
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunomodulatorsInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsMultiple Sclerosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2017/01/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBIOCAD JSC
China Registration ClassN/A

Develop Information

Active CompaniesBIOCAD JSC
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeL03AB07
Related LinksN/A